Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium

This publication has 17 references indexed in Scilit:

• Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma
  Journal of Clinical Oncology, 1999
• A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum
  European Journal Of Cancer, 1998
• Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
  Journal of Clinical Oncology, 1997
• Weekly gemcitabine in advanced bladder cancer: A preliminary report from a phase I study
  Annals of Oncology, 1994
• A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
  Journal of Clinical Oncology, 1992
• M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder
  European Journal of Cancer and Clinical Oncology, 1991
• Usefulness and Limitations of Methotrexate, Vinblastine, Doxorubicin And Cisplatin for the Treatment of Advanced Urothelial Cancer
  Journal of Urology, 1990
• A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.
  Journal of Clinical Oncology, 1990
• Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: Cause for concern
  Urology, 1989
• M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) Chemotherapy for Transitional Cell Carcinoma: The Princess Margaret Hospital Experience
  Journal of Urology, 1989